Blockchain Registration Transaction Record

Quantum BioPharma Advances Lucid-MS and unbuzzd in Podcast

Quantum BioPharma (QNTM) features Lucid-MS for MS and unbuzzd product in BioMedWire Podcast. Learn about Phase 2 trial plans and commercial strategy.

Quantum BioPharma Advances Lucid-MS and unbuzzd in Podcast

This news matters because Quantum BioPharma is advancing a potential treatment for multiple sclerosis, a debilitating disease affecting millions worldwide, while also generating revenue from a commercial product for alcohol metabolism. The company’s dual strategy reduces risk and provides near-term cash flow, making it an attractive opportunity for investors interested in biotech innovations.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x5670ad8684685178bcb96f8c52bb344a348ad2e0079c78c65550a8d91a8608b3
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintseekGA9J-ac4442355118731ca25cf321d3aa2c3e